Cobalt compounds

Cobalt's toxicity to the lungs was recognized in the 1940s-50s among workers in hard metal (cemented carbide) production — an industry making cutting tool inserts from tungsten carbide particles bound in a cobalt metal matrix [1]. The resulting occupational disease — hard metal lung disease (cobalt lung) — is a granulomatous lung condition similar to beryllium disease in its immunological mechanism [2]. Cobalt itself has been mined since the Middle Ages when it was used to create brilliant blue glass and ceramics (Cobalt blue, Prussian blue). Modern cobalt demand has exploded due to its essential role as a cathode material in lithium-ion batteries used in electric vehicles and electronics — the Democratic Republic of Congo produces approximately 70% of global cobalt from artisanal and large-scale mining operations [1]. Other important uses include cobalt driers in paints and varnishes, vitamin B12 (the only vitamin containing a metal atom — cobalt), and orthopedic metal-on-metal (MoM) hip implants that release cobalt ions through wear [2].

Occupational exposure occurs in cobalt refining, hard metal (cemented carbide) tool manufacturing and grinding, lithium-ion battery manufacturing, cobalt drier paint additive production, and diamond tool grinding (cobalt matrix) [1]. Patients with metal-on-metal hip implants are exposed through continuous cobalt ion release from articulating surfaces — several hundred thousand such implants were placed in the 2000s before the complications were recognized [2]. Artisanal gold and cobalt miners in the DRC face very high occupational exposure with inadequate protections [1]. The general population is exposed through diet (cobalt in green vegetables, meats, fish) at physiological levels, and through ambient air and dust in areas near cobalt processing facilities [2].

Cobalt's mechanisms are multiple and organ-specific. In the lungs, cobalt generates hydroxyl radicals via Fenton-type chemistry and activates immune cells, causing both direct oxidative injury and immune sensitization — up to 5% of hard metal workers develop giant cell interstitial pneumonitis [1]. Cobalt inhibits prolyl hydroxylase, stabilizing HIF-1alpha and producing a pseudohypoxia state — this explains polycythemia (excess red blood cell production, once deliberately exploited by athletes taking cobalt salts) and thyroid hormone inhibition [2]. Systemic cobaltism from MoM implants presents as cardiomyopathy, hypothyroidism, peripheral neuropathy, visual disturbance, and hearing loss. IARC classifies cobalt metal with tungsten carbide as Group 1 (carcinogenic to humans — lung cancer), while cobalt salts alone are Group 2A [1].

Hard metal workers (cemented carbide manufacturing and grinding) are at highest risk for cobalt lung disease [1]. Patients with recalled metal-on-metal hip implants (DePuy ASR, Stryker Rejuvenate) face systemic cobaltism requiring blood cobalt monitoring [2]. Battery manufacturing workers represent a growing exposure population as EV production scales up [1]. Artisanal cobalt miners in the DRC face severe occupational exposure with minimal protection [2].

1. Hard metal workers should have regular pulmonary function testing and work in facilities with local exhaust ventilation at grinding and pressing stations [1]. 2. Patients with metal-on-metal hip implants should have annual whole blood cobalt monitoring — levels above 7 µg/L require urgent orthopedic review [2]. 3. Battery manufacturing facilities should implement biological monitoring programs for cobalt and lithium [1]. 4. Hard metal grinding should be performed wet to reduce airborne dust [2].